Leukemia & lymphomaHumansArsenic TrioxideMaleElectrocardiographyLeukemia
Application of the QT nomogram to ECG monitoring of QT prolongation in arsenic trioxide for acute promyelocytic myeloid leukaemia.
Christopher Martin, Kate Hill, Katherine Isoardi
Published: 202510.1080/10428194.2025.2560077
Abstract
Arsenic trioxide is used in the treatment of acute promyelocytic myeloid leukemia. QT prolongation is a potential risk with arsenic therapy and formulae which correct the QT for heart rate (QTc) may over-estimate the risk of torsades de pointes. We a…
Preview only. Read the full abstract at the source